131 filings
Page 4 of 7
8-K
prazocg81321w1r u7ar
26 Jun 19
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
yix16jorv2wbsv
8 May 19
Intra-cellular Therapies Reports First Quarter 2019 Financial Results and Provides Corporate Update
7:35am
8-K
f1vhp
27 Feb 19
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2018 Financial Results and Provides Corporate Update
7:43am
8-K
jpb65fmgv24wexs4
18 Dec 18
Intra-Cellular Therapies Announces Update onITI-007-201 Clinical Trial for Treatment of Agitation in Patients with Probable Alzheimer’s Disease
8:39am
8-K
m76eycqdub8i1um9bc5o
12 Dec 18
Other Events
7:02am
8-K
xz0v32jq 02u4
11 Dec 18
Intra-Cellular Therapies Announces FDA Acceptance of New Drug Application for Lumateperone for the Treatment of Schizophrenia
7:15am
8-K
c3mpb
7 Nov 18
Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2018 Financial Results
7:17am
8-K
zeqrl1
2 Aug 18
Intra-Cellular Therapies Provides Corporate Update and Reports Second Quarter 2018 Financial Results
7:17am
8-K
7ju3c82j25czm2y9cavx
21 Jun 18
Departure of Directors or Certain Officers
4:32pm
8-K
ykc85bqi 0to
3 May 18
Intra-Cellular Therapies Reports First Quarter 2018 Financial Results and Provides Corporate Update
12:00am
8-K
j69zfa
13 Mar 18
Intra-Cellular Therapies Announces PositivePre-NDA Meeting with FDA for Lumateperone for the Treatment of Schizophrenia
12:00am
8-K
yuhb9upwr2wff3ipyr
1 Mar 18
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2017 Financial Results and Provides Corporate Update
12:00am
8-K
e8871l0l
8 Jan 18
Other Events
12:00am
8-K
3hx lhumh
8 Nov 17
Intra-Cellular Therapies Reports Third Quarter 2017 Financial
12:00am
8-K
bt56av
5 Oct 17
Intra-Cellular Therapies Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
12:00am
8-K
4n9l35
2 Oct 17
Intra-Cellular Therapies Announces Closing of $150 Million Public Offering of Common Stock
12:00am
8-K
wyfx1y9n tz
28 Sep 17
Entry into a Material Definitive Agreement
12:00am
8-K
0akp1f d2sr522
26 Sep 17
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
12:00am
8-K
shynkot rwd1lhiwg
7 Sep 17
Other Events
12:00am
8-K
sa2 ipcver31hdlc
23 Aug 17
Intra-Cellular Therapies Announces Positive Regulatory Update On Schizophrenia Program
12:00am